Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00114400 · ClinicalTrials.gov registry record · Phase 2
BVAIT: B-Vitamin Atherosclerosis Intervention Trial
A Phase 2 study, sponsored by National Institute on Aging (NIA).
- Completed
- Registry status
- Phase 2
- Development phase
- 506
- Enrollment target
NCT00114400: Completed Phase 2 study, sponsored by National Institute on Aging (NIA).
NCT00114400 is a Phase 2 study that has completed, run by National Institute on Aging (NIA). The registered enrollment target is 506 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (280% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00114400, a Phase 2 study, has completed, sponsored by National Institute on Aging (NIA).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 506 participants
- Enrollment target
Study Summary
The purpose of this study is to examine whether vitamin B supplementation will reduce the progression of early atherosclerosis in individuals over 40 years old and without clinical evidence of cardiovascular disease (CVD).
Interventions
- DRUG folic acid
- DRUG vitamin B12
- DRUG vitamin B6
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 506 participants |
| Start Date | 2000-11 |
| Est. Completion | 2007-02 |
| Phase | Phase 2 |
What the finished NCT00114400 record still lists
NCT00114400 is an interventional study that assigns participants to a tested intervention. The registered 506 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (280% higher).
The record links to 0 conditions, and to 3 interventions - of which folic acid is the first listed.
NCT00114400 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00114400 about?
NCT00114400 is a clinical study titled "BVAIT: B-Vitamin Atherosclerosis Intervention Trial". The purpose of this study is to examine whether vitamin B supplementation will reduce the progression of early atherosclerosis in individuals over 40 years old and without clinical evidence of cardiovascular disease (CVD).
What is the current status of trial NCT00114400?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 506 participants. The study started on 2000-11. Estimated completion is 2007-02.
What interventions are being tested in trial NCT00114400?
The interventions under investigation include: folic acid (DRUG), vitamin B12 (DRUG), vitamin B6 (DRUG).
Who is sponsoring clinical trial NCT00114400?
This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00114400's enrollment target sits among peer trials
506 69th of 2000 higher than 1,932 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05069428 · 506 participants · Phase 4
Delirium Reduction With Ramelteon
- NCT05797168 · 506 participants · Phase 1
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
- NCT06164717 · 507 participants · NA
Behavioral and Neural Characteristics of Adaptive Speech Motor Control
- NCT02115295 · 508 participants · Phase 2
Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia